ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 145 filers reported holding ITEOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,540,260 | -17.3% | 140,663 | -0.0% | 0.00% | – |
Q2 2023 | $1,863,093 | -67.8% | 140,717 | -66.9% | 0.00% | – |
Q1 2023 | $5,790,102 | -16.5% | 425,430 | +19.8% | 0.00% | -100.0% |
Q4 2022 | $6,933,111 | -18.5% | 354,998 | -20.5% | 0.00% | 0.0% |
Q3 2022 | $8,502,000 | -4.3% | 446,277 | +3.5% | 0.00% | 0.0% |
Q2 2022 | $8,883,000 | -55.0% | 431,196 | -29.7% | 0.00% | -50.0% |
Q1 2022 | $19,744,000 | -46.7% | 613,537 | -22.9% | 0.00% | -33.3% |
Q4 2021 | $37,038,000 | +70.4% | 795,481 | -1.2% | 0.00% | +50.0% |
Q3 2021 | $21,737,000 | +4.5% | 805,081 | -0.7% | 0.00% | 0.0% |
Q2 2021 | $20,797,000 | -25.8% | 810,781 | -1.1% | 0.00% | 0.0% |
Q1 2021 | $28,030,000 | +12.5% | 820,081 | +11.3% | 0.00% | 0.0% |
Q4 2020 | $24,921,000 | +58.3% | 736,881 | +15.5% | 0.00% | 0.0% |
Q3 2020 | $15,744,000 | – | 638,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,738,785 | $52,174,000 | 19.87% |
MPM BioImpact LLC | 1,745,943 | $33,260,000 | 7.88% |
Boxer Capital, LLC | 2,154,058 | $41,035,000 | 2.31% |
TANG CAPITAL MANAGEMENT LLC | 937,500 | $17,859,000 | 2.19% |
RA Capital Management | 4,417,259 | $84,149,000 | 1.80% |
BVF INC/IL | 1,810,835 | $34,496,000 | 1.42% |
Zebra Capital Management LLC | 12,271 | $234,000 | 0.89% |
Integral Health Asset Management, LLC | 195,000 | $3,715,000 | 0.72% |
Prairiewood Capital, LLC | 32,269 | $615,000 | 0.51% |
DAFNA Capital Management LLC | 97,560 | $1,859,000 | 0.50% |